Dynamic prediction and prognostic analysis of patients with cervical cancer: a landmarking analysis approach

被引:16
作者
Yang, Zijing [1 ]
Hou, Yawen [2 ]
Lyu, Jingjing [1 ]
Liu, Di [3 ]
Chen, Zheng [1 ]
机构
[1] Southern Med Univ, Guangdong Prov Key Lab Trop Dis Res, Sch Publ Hlth, Dept Biostat, Guangzhou, Peoples R China
[2] Jinan Univ, Dept Stat, Guangzhou, Peoples R China
[3] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Oncol, Xian, Peoples R China
基金
中国国家自然科学基金;
关键词
Cervical cancer; Dynamic prediction; Landmarking; Personalized prediction; Time-varying effect; CONDITIONAL SURVIVAL; NOMOGRAM; MODELS;
D O I
10.1016/j.annepidem.2020.01.009
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose: Providing up-to-date information on patient prognosis is important in determining the optimal treatment strategies. The currently available prediction models, such as the Cox model, are limited to making predictions from baseline and do not consider the time-varying effects of covariates. Methods: A total of 1501 cervical cancer patients from the Surveillance, Epidemiology, and End Results (SEER) database were included. We introduced three landmark dynamic prediction models (models 1-3) that explore the dynamic effects of prognostic factors to obtain 5-year dynamic survival rate predictions at different prediction times. The performances of these models were evaluated by Harrell's C-index and the Brier score using cross-validation. Results: Some variables did not meet the proportional hazards assumption, indicating that the constant hazard ratios were unreliable. Model 3, which showed the best performance for prediction, was selected as the final model. Significant time-varying effects were observed for age at diagnosis, International Federation of Gynecology and Obstetrics (FIGO) stage, lymph node metastasis, and histological subtypes. Three patients were as examples used to illustrate how the predicted probabilities change at different prediction times during follow-up. Conclusions: Model 3 can effectively incorporate covariates with time-varying effects and update the probability of surviving an additional 5 years at different prediction times. The use of the landmark approach may provide evidence for clinical decision making by updating personalized information for patients. (C) 2020 Elsevier Inc. All rights reserved.
引用
收藏
页码:45 / 51
页数:7
相关论文
共 28 条
[1]   ANALYSIS OF SURVIVAL BY TUMOR RESPONSE [J].
ANDERSON, JR ;
CAIN, KC ;
GELBER, RD .
JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (11) :710-719
[2]   Time-varying effect and long-term survival analysis in breast cancer patients treated with neoadjuvant chemotherapy [J].
Baulies, S. ;
Belin, L. ;
Mallon, P. ;
Senechal, C. ;
Pierga, J-Y ;
Cottu, P. ;
Sablin, M-P ;
Sastre, X. ;
Asselain, B. ;
Rouzier, R. ;
Reyal, F. .
BRITISH JOURNAL OF CANCER, 2015, 113 (01) :30-36
[3]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21609, 10.3322/caac.21492]
[4]   HPIP: a predictor of lymph node metastasis and poor survival in cervical cancer [J].
Cao, Shan ;
Sun, Jingxia ;
Lin, Shuai ;
Zhao, Lu ;
Wu, Di ;
Liang, Tian ;
Sheng, Wenji .
ONCOTARGETS AND THERAPY, 2017, 10 :4205-4211
[5]   Evaluation of the Time-Varying Effect of Prognostic Factors on Survival in Ovarian Cancer [J].
Chang, Chung ;
Chiang, An Jen ;
Wang, Hui-Ching ;
Chen, Wei-An ;
Chen, Jiabin .
ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (12) :3976-3980
[6]   Dynamic prediction in breast cancer: proving feasibility in clinical practice using the TEAM trial [J].
Fontein, D. B. Y. ;
Grand, M. Klinten ;
Nortier, J. W. R. ;
Seynaeve, C. ;
Kranenbarg, E. Meershoek-Klein ;
Dirix, L. Y. ;
van de Velde, C. J. H. ;
Putter, H. .
ANNALS OF ONCOLOGY, 2015, 26 (06) :1254-1262
[7]  
Fritz A., 2013, International classification of disease for oncology, Vthird
[8]  
Graf E, 1999, STAT MED, V18, P2529
[9]  
GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515
[10]  
Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO